Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy
- 1 March 2008
- Vol. 57 (3), 331-338
- https://doi.org/10.1136/gut.2007.136481
Abstract
Background: Despite the predominance of extensive disease in children with ulcerative colitis, data concerning severe paediatric ulcerative colitis are sparse. We reviewed rates and predictors of response to intravenous-corticosteroid therapy in a single-centre cohort with long-term follow-up. Methods: 99 children (49% males; age 2–17 years) were hospitalised (1991–2000) for treatment of severe ulcerative colitis (90% extensive; 49% new onset ulcerative colitis). Clinical, laboratory and radiographic data were reviewed. A population-based subset was used to assess incidence. Predictors of corticosteroid response were analysed using univariate and multivariate analyses at days 3 and 5 of therapy. Colectomy rates were calculated using Kaplan–Meier survival analyses. Results: 28% (95% CI, 23 to 34%) of children with ulcerative colitis resident in the Greater Toronto Area required admission for intravenous corticosteroid therapy, of whom 53 (53%; 95% CI, 44 to 63%) responded. Several predictors were associated with corticosteroid failure, but in multivariable modelling only C-reactive protein [OR = 3.5 (1.4 to 8.4)] and number of nocturnal stools [OR = 3.2 (1.6 to 6.6)] remained significant at both days 3 and 5. The Pediatric Ulcerative Colitis Activity Index (PUCAI), Travis and Lindgren’s indices strongly predicted non-response. Radiographically, the upper range of colonic luminal width was 40 mm in children younger than 11 years versus 60 mm in older patients. Cumulative colectomy rates at discharge, 1 year and 6 years were 42%, 58% and 61%, respectively. Conclusions: Children with ulcerative colitis commonly experience at least one severe exacerbation. Response to intravenous corticosteroids is poor. The PUCAI, determined at day 3 (>45 points) should be used to screen for patients likely to fail corticosteroids and at day 5 (>70 points) to dictate the introduction of second-line therapies.Keywords
This publication has 37 references indexed in Scilit:
- Review article: steroid resistance in inflammatory bowel disease – mechanisms and therapeutic strategiesAlimentary Pharmacology & Therapeutics, 2007
- Health Care Resource Utilization in Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2006
- Management of acute severe colitisBritish Medical Bulletin, 2005
- Severe ulcerative colitis: Prospective study of parameters determining outcomeJournal of Gastroenterology and Hepatology, 2004
- Medical treatment of severe ulcerative colitisAlimentary Pharmacology & Therapeutics, 2002
- Predictive Factors for the Response of Ulcerative Colitis Patients during the Acute-Phase TreatmentDigestion, 1990
- A Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active ProctocolitisScandinavian Journal of Gastroenterology, 1978
- Assessment of severity in colitis: a preliminary study.Gut, 1975
- Definition of megacolon in colitis.Gut, 1969
- Out-patient Treatment of Ulcerative ColitisBMJ, 1962